glp-1 suicidal thoughts MHRA finds evidence does not support a link between Glucagon-Like Peptide-1 (GLP-1) receptor agonists and and self-injurious and actions Study: GLP-1 Drugs Don't Raise

Trump signs executive order accelerating research into psychedelic drug therapies President Donald Trump signed an executive order Saturday that aims to accelerate research and approval of psychedelic-based therapies, especially drugs like ibogaine, for conditions such as PTSD, depression and addiction

If weight loss is your primary goal, is Byetta the right choice for you

Antibodies also have the advantage of extended circulation through the neonatal Fc receptor (FcRn), which prolongs their half-life and reduces the frequency of dosing

In the case that one has at least one medical condition resulting from obesity, like hypertension, diabetes, sleep apnea, etc., this drug could be used starting at a BMI of 27, which would be equivalent to a lower weight compared to healthier individuals